Renal Denervation

This channel includes news and new technology innovations for renal denervation used to treat hypertension. Renal denervation is a catheter-based therapy. The catheter is into the renal artery and delivers radio-frequency energy to ablate the nerves in the vessel wall that regulate vasoconstriction. This leaves the vessel permanently in the widest open position to allow greater blood flow to the kidneys. This enables greater filtration of the blood and removal of excess water that causes hypertension

News | August 22, 2013
August 22, 2013 — Qinghui Chen, assistant professor in Michigan Tech’s kinesiology and integrative physiology...
News | August 02, 2013
August 2, 2013 — Mercator MedSystems has been issued U.S. Patent 8,465,752, which protects the company’s sole U.S....
MEDTRONIC, symplicity renal denervation catheter

The Medtronic Symplicity catheter was the first renal denervation system to prove in clinical trials the therapy can lower drug-resistant hypertension.

Feature | July 30, 2013 | Dave Fornell
One of the exciting new frontiers for interventional cardiology is the use of renal denervation therapy to treat...
FDA US device innovation

The delay in being able to bring new medical device advances to market in the United States, such as transcatheter aortic valves and left atrial appendage occluders, has raised the question of the U.S. leadership role in technology innovation.

Feature | July 03, 2013 | Anita Asgar, M.D., FSCAI
The field of interventional cardiology is one of constant change and innovation. The past 10 years have documented...
News | June 13, 2013
June 13, 2013 — St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) approval to begin the EnligHTN...
Boston Scientific Vessix Renal Denervation System Hypertension Therapies
News | June 06, 2013
June 6, 2013 — Boston Scientific Corporation reported interim data from the REDUCE-HTN clinical program, which...
News | June 03, 2013
June 3, 2013 — St. Jude Medical Inc. announced that the company’s EnligHTN multi-electrode renal denervation system ...
News | May 30, 2013
May 30, 2013 — Kona Medical announced three and six month results from the WAVE I study, a first-in-man study...
News | May 17, 2013
May 17, 2013 — Can high blood pressure be safely reduced and controlled by “disconnecting” nerves in the kidneys? That...
News | April 24, 2013
April 24, 2013 — Cardiosonic Inc. announced the completion of the first phase of patient enrollment in its first-in-man...
Feature | April 01, 2013
April 1, 2013 — Rox Medical announced enrollment of the first U.K. patients in the CONTROL-HTN international randomized...
Symplicity Renal Denervation System Medtronic Inc. Parallel Review Program
Feature | March 12, 2013
March 12, 2013 — Medtronic Inc. announced the U.S. Food and Drug Administration (FDA) and the Centers for Medicare and...
Renal Denervation Clinical Study EnligHTNment Trial St. Jude Medical
Feature | March 01, 2013
March 1, 2013 — St. Jude Medical Inc. announced plans for a new landmark clinical study that will evaluate whether...
St. Jude Medical EnligHTN II trial Renal Denervation System
Feature | February 13, 2013
February 13, 2013 — St. Jude Medical Inc. announced enrollment of the first patient in the EnligHTN II trial. This post...
Feature | February 04, 2013 | Dave Fornell
My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology and trends. With...